Find the latest oncology news for your sub-specialty area
ASCO 2026: EMERALD-3 study shows that new combination treatment strategies for embolization-eligible hepatocellular carcinoma are superior
Results from the Phase 3 EMERALD-3 study found that combining the standard treatment of transarterial…